Anti-precision medicine

  1. At its worst, precision medicine can result in bias. This can be especially true if the criteria for excluding certain patient populations from a therapy is based on prior medical history or demographic criteria.
Coral’s 3-step approach to anti-precision medicine
History of TNFi: From in vitro to in vivo and back again
  1. trying a similar approach on other mechanisms (ex: IL12/23)
  2. working with pharma partners on downstream development



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Atray Dixit

Atray Dixit

CEO@Coral: patient diversity + improving therapies. MIT PhD 2018: single cell seq + CRISPR (Perturb-seq, Shuffle-seq)